| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| anrukinzumab | interleukin-13 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Ulcerative Colitis[MeSHID:D003093] Asthma[MeSHID:D001249] |
15.91 | phase 2 | inhibitor |
| anrukinzumab | interleukin-13 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Ulcerative Colitis[MeSHID:D003093] Asthma[MeSHID:D001249] |
15.91 | phase 2 | unknown |
| click here to return to the previous page | ||||||||